Who is sponsoring NCT00711607?

NCT00711607 is sponsored by Organon and Co.

What drugs are being tested in NCT00711607?

Interventions: nomegestrol acetate and estradiol.

What is the status of NCT00711607?

NCT00711607 is currently COMPLETED.

Last reviewed 2022-02-03 · How we verify

A Trial to Assess the Pharmacokinetic Profile (e.g., Uptake, Distribution and Excretion of a Substance in the Body) of Nomegestrol Acetate (NOMAC), Estradiol (E2) and Estrone (E1) After Multiple and Single Dose Administration of the Combined Oral Contraception NOMAC-E2 (COMPLETED)(P05822)

NCT00711607 PHASE1 COMPLETED

The primary purpose of this trial is to assess the pharmacokinetic profile of NOMAC, E2 and E1 after multiple and single dose administration of the combined oral contraceptive NOMAC-E2

Details

Lead sponsor	Organon and Co
Phase	PHASE1
Status	COMPLETED
Enrolment	25
Start date	Tue May 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Sep 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Healthy

Interventions

nomegestrol acetate and estradiol